drugset / Trial / NCT03595085

Catheter Directed Interventions in Pulmonary Embolism

NCT03595085

Unknown 60 enrolled Assiut University
RandomizedParallel-groupOpen-labelTreatment

Summary

Evaluating the safety and outcomes of catheter directed thrombolysis following catheter fragmentation in acute high risk pulmonary embolism

Timeline

Start
2018-09-01
Primary completion
2020-10-01
Completion
2021-03-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Streptokinase Protein / enzyme biologic 100000 iu Intravenous

Indications